CardieX Limited announced that appointment of Steven Kesten M.D. as New Chief Medical Officer (CMO) and Mark Gorelick PhD. as New Chief Product Officer (CPO). Steven Kesten M.D. joins as new Chief Medical Officer. Steven comes to us with a background which includes similar positions at Uptake Medical and global Pharma giant Boehringer Ingelheim. Steven will initially be focused on developing and leading clinical advocacy programs as well as leading the efforts of the Company in developing expanded coverage for products with insurers, Medicare and Medicaid, and the health payer networks in the USA. Mark Gorelick PhD. joins as new Chief Product Officer, a newly created position focused on leading product development and delivery across the expanse of new products in development. Mark is principally charged with working closely with myself and leading the product teams in creating, developing, and delivering to market innovative and industry changing health technologies that disrupt the existing health-tech market.